Sarcoma  >>  glucopyranosyl lipid A (G100)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glucopyranosyl lipid A (G100) / Merck (MSD)
NCT02387125: Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Checkmark From trial for locally advanced, relapsed, or metastatic cancer at ASCO 2017
Jun 2017 - Jun 2017: From trial for locally advanced, relapsed, or metastatic cancer at ASCO 2017
Checkmark Early data from ovarian cancer
May 2017 - May 2017: Early data from ovarian cancer
Checkmark For solid tumors
More
Terminated
1b
79
US
CMB305, G100, Metronomic CPA, Cytoxan Tablets
Immune Design
Sarcoma, Melanoma, Non-small Cell Lung Cancer, Ovarian Cancer
03/19
03/19

Download Options